Incidence and associated factors of cetuximab-induced hypersensitivity infusion reactions in 1392 cancer patients treated in four French areas: a possible association with Lyme disease?

Peer Review reports

Original Submission
28 Dec 2021	Submitted	Original manuscript
Resubmission - Version 2
	Submitted	Manuscript version 2
Resubmission - Version 3
	Submitted	Manuscript version 3
5 Jun 2022	Reviewed	Reviewer Report
25 Sep 2022	Reviewed	Reviewer Report - Shinya Suzuki
10 Oct 2022	Author responded	Author comments - Claire Carlier
Resubmission - Version 4
10 Oct 2022	Submitted	Manuscript version 4
Publishing
17 Oct 2022	Editorially accepted
25 Nov 2022	Article published	10.1186/s12885-022-10192-4

Back to article page